Probi AB

Equities

PROB

SE0001280355

Pharmaceuticals

Market Closed - Nasdaq Stockholm 10:32:17 2024-04-26 am EDT 5-day change 1st Jan Change
209 SEK +1.95% Intraday chart for Probi AB -5.43% +2.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Probi AB, Q1 2024 Earnings Call, Apr 23, 2024
Probi AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Probi AB Strengthens Its Brand Position and Expands in the Nordics CI
Transcript : Probi AB, Q4 2023 Earnings Call, Jan 26, 2024
Probi AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Probi AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Probi AB Proposes Dividend for the Fiscal Year 2023 CI
Transcript : Probi AB, Q3 2023 Earnings Call, Oct 24, 2023
Probi AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Thunderful Group Names New CFO MT
Sweden’s Probi Names New CFO MT
Probi AB Appoints Per Lindblad as New CFO, Effective from 1st of November, 2023 CI
Probi Launches Two New Concepts Together with Clasado Biosciences at Supply Side West CI
Probi Sensia to Be Launched by Probi at SupplySide West in October 2023 CI
New Clinical Study Shows Clear Benefits of Probi's Probiotics for Metabolic Health CI
Transcript : Probi AB, Q2 2023 Earnings Call, Jul 18, 2023
Probi AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Probiotics Group Probi's Finance Chief to Depart MT
Probi AB Announces Resignation of Henrik Lundkvist as Chief Financial Officer CI
Sweden’s Probi, UK’s Clasado Biosciences to Collaborate on Synbiotic Product Development MT
Probi AB Takes over All Distribution of Blis K12 and Blis M18 in North America CI
Probi AB Approves Dividend for the Financial Year 2022 CI
Transcript : Probi AB, Q1 2023 Earnings Call, Apr 26, 2023
Probi AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Probi AB Appoints Anita Johansen as Chief Executive Officer, Effective April 1, 2023 CI
Chart Probi AB
More charts
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. PROB Stock
  4. News Probi AB
  5. Probi : Snaps Up 13% Stake In Blis Technologies For $6 Million